Neutrophils Are Not Less Sensitive Than Other Blood Leukocytes to the Genomic Effects of Glucocorticoids

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hirsch, Gaelle ^a   Lavoie Lamoureux, Anouk ^a   Beauchamp, Guy ^a   Lavoie, Jean Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUTAMATE AMMONIA LIGASE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CELL; CELL ISOLATION; CELL POPULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; GENOMICS; GLUTAMINE SYNTHETASE GENE; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE; MICROSCOPY; NEUTROPHIL; NONHUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HORSES; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; NEUTROPHILS; RNA, MESSENGER;

EQUIDAE;

EID: 84866331189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044606     Document Type: Article

References (55)

1. Cassatella MA, (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 73: 369-509.
2. Filep JG, El Kebir D, (2009) Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J Cell Biochem 108: 1039-1046.
3. Schleimer RP, (1990) Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 141: S59-69.
4. Schleimer RP, (2004) Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 1: 222-230.
5. Schleimer RP, Freeland HS, Peters SP, Brown KE, Derse CP, (1989) An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 250: 598-605.
6. Cox G, (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154: 4719-4725.
7. Meagher LC, Cousin JM, Seckl JR, Haslett C, (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156: 4422-4428.
8. Barnes PJ, Adcock IM, (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905-1917.
9. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV, (2000) Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am J Respir Crit Care Med 161: 1185-1190.
10. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, et al. (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160: 1001-1008.
11. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, et al. (1997) Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156: 737-743.
12. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ (2007) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev: CD002991.
13. Barnes PJ (2007) New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119: 1055-1062; quiz 1063-1054.
14. Al-Mokdad M, Shibata F, Takano K, Nakagawa H, (1998) Differential production of chemokines by phagocytosing rat neutrophils and macrophages. Inflammation 22: 145-159.
15. Strandberg K, Blidberg K, Sahlander K, Palmberg L, Larsson K, (2010) Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils. Pulm Pharmacol Ther 23: 316-323.
16. Nupponen I, Repo H, Kari A, Pohjavuori M, Andersson S, (2002) Early dexamethasone decreases expression of activation markers on neutrophils and monocytes in preterm infants. Acta Paediatr 91: 1200-1207.
17. Wertheim WA, Kunkel SL, Standiford TJ, Burdick MD, Becker FS, et al. (1993) Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol 151: 2166-2175.
18. Burton JL, Kehrli ME Jr, Kapil S, Horst RL, (1995) Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol 57: 317-325.
19. Weber PS, Toelboell T, Chang LC, Tirrell JD, Saama PM, et al. (2004) Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils. J Leukoc Biol 75: 815-827.
20. Lecoq L, Vincent P, Lavoie-Lamoureux A, Lavoie JP, (2009) Genomic and non-genomic effects of dexamethasone on equine peripheral blood neutrophils. Vet Immunol Immunopathol 128: 126-131.
21. Joubert P, Silversides DW, Lavoie JP, (2001) Equine neutrophils express mRNA for tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-gamma. Equine Vet J 33: 730-733.
22. Lavoie-Lamoureux A, Beauchamp G, Quessy S, Martin JG, Lavoie JP, (2012) Systemic inflammation and priming of peripheral blood leukocytes persist during clinical remission in horses with heaves. Vet Immunol Immunopathol 146: 35-45.
23. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM, (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101-110.
24. Lavoie-Lamoureux A, Moran K, Beauchamp G, Mauel S, Steinbach F, et al. (2010) IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression profile with enhanced neutrophil chemotactic mediator release ex vivo. Am J Physiol Lung Cell Mol Physiol 299: L472-482.
25. Fialkow L, Fochesatto Filho L, Bozzetti MC, Milani AR, Rodrigues Filho EM, et al. (2006) Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 10: R155.
26. Barnes PJ, (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163: 29-43.
27. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E, (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75: 1-12.
28. Pujols L, Mullol J, Picado C, (2007) Alpha and beta glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep 7: 93-99.
29. Dandona P, Mohanty P, Hamouda W, Aljada A, Kumbkarni Y, et al. (1999) Effect of dexamethasone on reactive oxygen species generation by leukocytes and plasma interleukin-10 concentrations: a pharmacodynamic study. Clin Pharmacol Ther 66: 58-65.
30. Chandrasekhar S, Souba WW, Abcouwer SF, (1999) Identification of glucocorticoid-responsive elements that control transcription of rat glutamine synthetase. Am J Physiol 276: L319-331.
31. Gaunitz F, Heise K, Schumann R, Gebhardt R, (2002) Glucocorticoid induced expression of glutamine synthetase in hepatoma cells. Biochem Biophys Res Commun 296: 1026-1032.
32. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, et al. (2004) Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 151: 397-406.
33. Leclere M, Lefebvre-Lavoie J, Beauchamp G, Lavoie JP, (2010) Efficacy of oral prednisolone and dexamethasone in horses with recurrent airway obstruction in the presence of continuous antigen exposure. Equine Vet J 42: 316-321.
34. Buttgereit F, Brand MD, Burmester GR, (1999) Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 58: 363-368.
35. Grady JA, Davis EG, Kukanich B, Sherck AB, (2010) Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses. Am J Vet Res 71: 831-839.
36. Czock D, Keller F, Rasche FM, Haussler U, (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44: 61-98.
37. Xu J, Winkler J, Derendorf H, (2007) A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma. J Pharmacokinet Pharmacodyn 34: 355-372.
38. Walajtys-Rode E, Dabrowski A, Grubek-Jaworska H, Machnicka B, Droszcz W, (1988) Binding of dexamethasone and its effect on histamine release from rat mast cells. Int J Immunopharmacol 10: 925-930.
39. Burrows GE, (1981) Dose-response of ponies to parenteral Escherichia coli endotoxin. Can J Comp Med 45: 207-210.
40. Berczi I, Bertok L, Bereznai T, (1966) Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can J Microbiol 12: 1070-1071.
41. Palsson-McDermott EM, O'Neill LA, (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162.
42. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK, (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168: 4701-4710.
43. Wang XQ, Zhou X, Zhou Y, Rong L, Gao L, et al. (2008) Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors. Respirology 13: 772-780.
44. Cassatella MA, (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16: 21-26.
45. Saffar AS, Ashdown H, Gounni AS, (2011) The molecular mechanisms of glucocorticoids-mediated neutrophil survival. Curr Drug Targets 12: 556-562.
46. Saffar AS, Dragon S, Ezzati P, Shan L, Gounni AS (2008) Phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils. J Allergy Clin Immunol 121: 492-498 e410.
47. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A, (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012-2020.
48. Langereis JD, Oudijk EJ, Schweizer RC, Lammers JW, Koenderman L, et al. (2011) Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1beta synthesis by human neutrophils. Eur Respir J 37: 406-415.
49. Cohen (2007) Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet Journal of Rare Diseases.
50. Leclere M, Lavoie-Lamoureux A, Lavoie JP, (2011) Heaves, an asthma-like disease of horses. Respirology 16: 1027-1046.
51. Lavoie JP, Pasloske K, Joubert P, Cordeau ME, Mancini J, et al. (2006) Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses. J Vet Intern Med 20: 175-181.
52. Lavoie JP, Leguillette R, Pasloske K, Charette L, Sawyer N, et al. (2002) Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction. Am J Vet Res 63: 579-585.
53. Barnes PJ, (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120: 76-85.
54. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, et al. (2001) High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193: 585-593.
55. Vazquez-Tello A, Semlali A, Chakir J, Martin JG, Leung DY, et al. (2010) Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy 40: 1312-1322.